WESTFORD, Mass., Feb. 6, 2013 /PRNewswire/ -- Cynosure, Inc.
(NASDAQ: CYNO) today announced that President and Chief Executive
Officer Michael Davin and
Tim Baker, the Company's Executive
Vice President and Chief Financial Officer, will participate in the
Leerink Swann Global Healthcare Conference 2013 in
New York City.
The event, which will be conducted in a "fireside chat" format,
is scheduled for 12:00 p.m. (ET) Wednesday,
February 13. Both live and archived audio webcasts of the
event will be accessible through a link on the Investor Relations
section of the Company's website, www.cynosure.com.
About Cynosure, Inc.
Cynosure, Inc. develops and
markets aesthetic treatment systems that are used by physicians and
other practitioners to perform non-invasive and minimally invasive
procedures to remove hair, treat vascular and pigmented lesions,
remove multi-colored tattoos, rejuvenate the skin, liquefy and
remove unwanted fat through laser lipolysis, reduce cellulite and
treat onychomycosis. Cynosure's products include a broad range of
laser and other light-based energy sources, including Alexandrite,
pulse dye, Q-switched, Nd:YAG and diode lasers, as well as intense
pulsed light. Cynosure was founded in 1991. For corporate or
product information, contact Cynosure at 800-886-2966, or visit
www.cynosure.com.
Contact:
Scott Solomon
Vice President
Sharon Merrill Associates, Inc.
617.542.5300
cyno@investorrelations.com
SOURCE Cynosure, Inc.